Michael Kostoff

Author's posts

SASKATCHEWAN DEPLOYS COVID-19 NOVARI E-REFERRAL & CENTRAL INTAKE SYSTEM

KINGSTON ON & REGINA SK, August 10, 2020 – The Saskatchewan Health Authority (SHA) in partnership with eHealth Saskatchewan has deployed the Novari eReferral & central intake system province-wide for COVID-19 testing and assessment referrals.  Working closely together, SHA, eHealth and Novari Health staff quickly configured the Novari technology to facilitate COVID-19 referrals to help ensure …

Continue reading

VIVE + MARRONE BIO JOIN FORCES TO BRING NEXT-GENERATION CROP PROTECTION SOLUTIONS TO GROWERS

Toronto, ON and Davis, CA — August 6, 2020 — Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI), an international leader in sustainable bioprotection and plant health solutions, and Vive Crop Protection, a leader in Precision Chemistry solutions and owner of the patented Allosperse® technology, announced an agreement that will provide a suite of ground-breaking products …

Continue reading

NATSO WELCOMES SMOOTH COMMERCE AS A PARTNER IN PROVIDING MOBILE APP AND WEB ORDERING TO TRUCKSTOP AND TRAVEL CENTER OPERATORS

JULY 24, 2020 — NATSO is excited to announce a new partnership with Smooth Commerce — a leading branded mobile app and web ordering provider. Smooth Commerce provides truckstop and travel center operators with a customizable platform that allows customers to order ahead for pickup and delivery, pay, earn loyalty and more. Smooth Commerce’s digital platform will allow …

Continue reading

NOVARI HEALTH WINS MICROSOFT’S 2020 CRISIS CHAMPION IMPACT AWARD FOR ONTARIO WIDE VIRTUAL CARE CLINIC TO SUPPORT COVID-19 RESPONSE

KINGSTON, July 24, 2020: The Microsoft Crisis Champion IMPACT award recognizes the Microsoft partner who has had a significant impact on people, businesses, and/or communities in Canada, with quick response, innovative solutions, and empathy toward those affected by the coronavirus. On Tuesday, July 22, 2020, it was announced virtually at the annual Microsoft Inspire Conference …

Continue reading

PROMIS NEUROSCIENCES AND BC NEUROIMMUNOLOGY ANNOUNCE REVENUE-SHARING JOINT VENTURE AGREEMENT TO DEVELOP AND OFFER BLOOD-BASED DIAGNOSTIC TESTS FOR ALZHEIMER’S DISEASE

TORONTO, Ontario and CAMBRIDGE, Mass. — July 9, 2020 —ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a company with unique, core technology to predict novel targets (peptide antigens) on the molecular surface of complex, misfolded proteins, and BC Neuroimmunology Lab (BCNI), have entered into a revenue-sharing joint venture (JV) agreement to develop and offer highly …

Continue reading